Literature DB >> 8370570

Dopamine formation, from its immediate precursor 3,4-dihydroxyphenylalanine, along the rat digestive tract.

M A Vieira-Coelho1, P Soares-da-Silva.   

Abstract

The formation of dopamine, from L-3,4-dihydroxyphenylalanine (L-dopa), in fragments of non-glandular and glandular stomach, duodenum, jejunum, ileum and proximal and distal colon of the rat was examined. The deamination of newly-formed dopamine into 3,4-dihydroxyphenylacetic acid (dopac) was also studied. The synthesis of dopamine in tissues incubated with 500 microM L-dopa for 20 min in conditions of catechol-O-methyltransferase (Comt) inhibition was found to be in the duodenum, jejunum and ileum 2-fold that in the proximal colon, 6-fold that in the glandular stomach and 120-fold that in the non-glandular stomach and distal colon. The formation of dopac in these tissues followed the pattern of amine formation. In the jejunum, the formation of dopamine and dopac was found to be dependent on the concentration of L-dopa (50 to 5000 microM) used. In another set of experiments, it was found that the formation of dopamine in jejunal segments loaded with increasing concentrations of L-dopa (50, 100 and 500 microM) was a time-dependent process. The rate constant (k) of formation of dopamine as a function of time was found to be similar (0.050 +/- 0.005) with either concentration of L-dopa; the rate constant of dopac formation in these experiments was, in contrast, found to be greater at the highest concentrations of L-dopa (100 and 500 microM). Aromatic L-amino acid decarboxylase (Aaad) activity determined in homogenates of the jejunal mucosa was found to be twice that observed in homogenates of the remaining jejunal wall (muscular).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8370570     DOI: 10.1111/j.1472-8206.1993.tb00237.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  15 in total

1.  Anti-incretin, Anti-proliferative Action of Dopamine on β-Cells.

Authors:  Antonella Maffei; Ann Marie Segal; Juan Carlos Alvarez-Perez; Adolfo Garcia-Ocaña; Paul E Harris
Journal:  Mol Endocrinol       Date:  2015-03-09

2.  The role of extraneuronal amine transport systems for the removal of extracellular catecholamines in the rabbit.

Authors:  B Friedgen; R Wölfel; H Russ; E Schömig; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

Review 3.  Aromatic L-amino acid decarboxylase: a neglected and misunderstood enzyme.

Authors:  M D Berry; A V Juorio; X M Li; A A Boulton
Journal:  Neurochem Res       Date:  1996-09       Impact factor: 3.996

Review 4.  Case of levodopa toxicity from ingestion of Mucuna gigantea.

Authors:  Gary G Tse; Brian B Kim; Aaron M McMurtray; Beau K Nakamoto
Journal:  Hawaii J Med Public Health       Date:  2013-05

5.  Ontogenic aspects of D1 receptor coupling to G proteins and regulation of rat jejunal Na+, K+ ATPase activity and electrolyte transport.

Authors:  M A Vieira-Coelho; P Soares-da-Silva
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

6.  Regulation of Cl- secretion by alpha2-adrenergic receptors in mouse colonic epithelium.

Authors:  Rebecca S Lam; Ernst M App; Drew Nahirney; Artur J Szkotak; Maria A Vieira-Coelho; Malcolm King; Marek Duszyk
Journal:  J Physiol       Date:  2003-02-21       Impact factor: 5.182

7.  Impaired synthesis or cellular storage of norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel disease.

Authors:  F Magro; M A Vieira-Coelho; S Fraga; M P Serrão; F Tavarela Veloso; Tomé Ribeiro; P Soares-da-Silva
Journal:  Dig Dis Sci       Date:  2002-01       Impact factor: 3.199

8.  Stomach gastrin is regulated by sodium via PPAR-α and dopamine D1 receptor.

Authors:  Peng Xu; John J Gildea; Chi Zhang; Prasad Konkalmatt; Santiago Cuevas; Dora Bigler Wang; Hanh T Tran; Pedro A Jose; Robin A Felder
Journal:  J Mol Endocrinol       Date:  2020-02       Impact factor: 5.098

Review 9.  Gastrointestinal dopamine as an anti-incretin and its possible role in bypass surgery as therapy for type 2 diabetes with associated obesity.

Authors:  Suleman Chaudhry; Marilia Bernardes; Paul E Harris; Antonella Maffei
Journal:  Minerva Endocrinol       Date:  2015-10-27       Impact factor: 2.184

Review 10.  The dopaminergic system in autoimmune diseases.

Authors:  Rodrigo Pacheco; Francisco Contreras; Moncef Zouali
Journal:  Front Immunol       Date:  2014-03-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.